|
|
|||||||||
CLINICAL INVESTIGATIONS |
Departments of Nuclear Medicine and Neurology, Chang Gung Memorial Hospital at Lin-Ko and Keelung, Taipei Medical Center and School of Medicine, Chang Gung University; and Institute of Nuclear Energy Research, Lung-Tan, Taiwan
The aim of this study was to use brain SPECT to differentiate vascular parkinsonism (VP) from Parkinsons disease. Methods: Fourteen VP patients (age range, 5987 y; mean age, 70 ± 7.5 y), 30 Parkinsons disease patients (age range, 5484 y; mean age, 65 ± 8.8 y), and 26 healthy (control) individuals (age range, 5085 y; mean age, 60 ± 9 y) were examined. A 925-MBq (25 mCi) dose of 99mTc-TRODAT-1 was injected intravenously, and brain SPECT images were acquired 4 h after injection. The ratio of specific to nonspecific striatal 99mTc-TRODAT-1 binding was measured and compared. Results: After a region-of-interest analysis of the images from VP patients, Parkinsons disease patients, and healthy volunteers was performed to obtain ratios of putamen to occipital and striatal to occipital binding as a measurement of specific binding to the dopamine transporters in these regions of the brain, where dopamine neurons are concentrated, the specific binding in the 14 VP patients was slightly lower than but not statistically different from that of the healthy individuals in both putamen and caudate areas. A significant decrease in uptake of 99mTc-TRODAT-1 in the striatum (P < 0.01) was found in Parkinsons disease patients. Reduction of the uptake was more pronounced in the contralateral putamen of Parkinsons disease patients than that of VP patients (P < 0.001). A significant bilateral striatal asymmetry was also observed in Parkinsons disease patients but not in VP patients (P < 0.01). Conclusion: Our findings clearly show that, for VP patients, 99mTc-TRODAT-1 SPECT is a reliable method to differentiate VP from Parkinsons disease. Further studies, including those to differentiate Parkinsons disease from arteriosclerotic parkinsonism and patients with both VP and Parkinsons disease, are needed to help rule out the possibility of Parkinsons disease as early as possible.
Key Words: Parkinsons disease vascular parkinsonism 99mTc-TRODAT-1
This article has been cited by other articles:
![]() |
G Kagi, K P Bhatia, and E Tolosa The role of DAT-SPECT in movement disorders J. Neurol. Neurosurg. Psychiatry, January 1, 2010; 81(1): 5 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ter-Antonyan, R. J. Jaszczak, K. L. Greer, J. E. Bowsher, S. D. Metzler, and R. E. Coleman Combination of Converging Collimators for High-Sensitivity Brain SPECT J. Nucl. Med., September 1, 2009; 50(9): 1548 - 1556. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lorberboym, R. Djaldetti, E. Melamed, M. Sadeh, and Y. Lampl 123I-FP-CIT SPECT Imaging of Dopamine Transporters in Patients with Cerebrovascular Disease and Clinical Diagnosis of Vascular Parkinsonism J. Nucl. Med., October 1, 2004; 45(10): 1688 - 1693. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Weng, T.-C. Yen, M.-C. Chen, P.-F. Kao, K.-Y. Tzen, R.-S. Chen, S.-P. Wey, G. Ting, and C.-S. Lu Sensitivity and Specificity of 99mTc-TRODAT-1 SPECT Imaging in Differentiating Patients with Idiopathic Parkinson's Disease from Healthy Subjects J. Nucl. Med., March 1, 2004; 45(3): 393 - 401. [Abstract] [Full Text] |
||||
![]() |
C.-S. Lu, Y.-H. Weng, M.-C. Chen, R.-S. Chen, K.-Y. Tzen, S.-P. Wey, G. Ting, H.-C. Chang, and T.-C. Yen 99mTc-TRODAT-1 Imaging of Multiple System Atrophy J. Nucl. Med., January 1, 2004; 45(1): 49 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-C. Yen, K.-Y. Tzen, M.-C. Chen, Y.-H. W. Chou, R.-S. Chen, C.-J. Chen, S.-P. Wey, G. Ting, and C.-S. Lu Dopamine Transporter Concentration Is Reduced in Asymptomatic Machado-Joseph Disease Gene Carriers J. Nucl. Med., February 1, 2002; 43(2): 153 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-S. Huang, S.-Z. Lin, J.-C. Lin, S.-P. Wey, G. Ting, and R.-S. Liu Evaluation of Early-Stage Parkinson's Disease with 99mTc-TRODAT-1 Imaging J. Nucl. Med., September 1, 2001; 42(9): 1303 - 1308. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |